{"id":"NCT01037244","sponsor":"Warner Chilcott","briefTitle":"Treatment of Erectile Dysfunction I","officialTitle":"Randomized, Placebo-controlled, Double-Blind, Parallel Design, Phase 3 Study to Assess the Safety and Efficacy of Udenafil Tablets in Male Subjects With Erectile Dysfunction","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09","primaryCompletion":"2010-03","completion":"2010-03","firstPosted":"2009-12-22","resultsPosted":"2011-12-22","lastUpdate":"2011-12-22"},"enrollment":618,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Erectile Dysfunction"],"interventions":[{"type":"DRUG","name":"Udenafil","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Udenafil 50 mg","type":"EXPERIMENTAL"},{"label":"Udenafil 100 mg","type":"EXPERIMENTAL"},{"label":"Udenafil 150 mg","type":"EXPERIMENTAL"}],"summary":"Randomized, placebo-controlled, double-blind, parallel design, Phase 3 study to evaluate the safety and efficacy of udenafil, an orally administered, potent and selective inhibitor of PDE-5 versus placebo for the treatment of subjects with erectile dysfunction (ED).","primaryOutcome":{"measure":"Change in Erectile Function Domain Assessed by International Index of Erectile Function (IIEF), Baseline to Final Visit/Week 12, mITT (Modified Intent-to-Treat), LOCF (Last Observation Carried Forward)","timeFrame":"Baseline and Week 12","effectByArm":[{"arm":"Udenafil 50 mg","deltaMin":4.85,"sd":7.78},{"arm":"Udenafil 100 mg","deltaMin":6.98,"sd":7.82},{"arm":"Udenafil 150mg","deltaMin":7.76,"sd":8.53},{"arm":"Placebo","deltaMin":-0.19,"sd":5.31}],"pValues":[{"comp":"OG000 vs OG003","p":"<0.0001"},{"comp":"OG001 vs OG003","p":"<0.0001"},{"comp":"OG002 vs OG003","p":"<0.0001"}]},"eligibility":{"minAge":"19 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":36,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":155},"commonTop":["Headache","Nasopharyngitis","Upper Respiratory Tract Infection","Flushing","Nasal Congestion"]}}